Helenius I J, Tikkanen H O, Haahtela T
Department of Allergology, Helsinki University Central Hospital, Finland.
Br J Sports Med. 1998 Jun;32(2):125-9. doi: 10.1136/bjsm.32.2.125.
To study factors affecting the occurrence of exercise induced bronchospasm (EIB) in elite runners.
Fifty eight elite runners, 79% of them belonging to Finnish national teams, volunteered. The athletes answered a questionnaire on respiratory symptoms. Skin prick tests were used to investigate atopy, and spirometry to examine lung function at rest and after an exercise challenge test (ECT) at subzero temperature in the winter and after a similar ECT in the summer at the end of the birch pollen season.
Definitive EIB (a post-exercise reduction of 10% or more in forced expiratory volume in one second (FEV1) was observed in five (9%) of the 58 runners. A subgroup consisting of 19 non-atopic symptom-free runners with no family history of asthma was used to establish a normal range for post-exercise reduction in FEV1. When this group's mean exercise induced change in FEV1 minus 2 SDs (a reduction of 6.5% or more in FEV1) was taken as the lower limit of the reference range, 15 (26%) of the runners had probable EIB in either the winter or the pollen season. The occurrence of probable EIB depended on atopy (odds ratio increased with number of positive skin prick test reactions, p < 0.05). Nine (22%) of the 41 runners, challenged in both the winter and the pollen season, had probable EIB only in the winter, and three (7%) had it only in the pollen season. Only one runner (2%) had EIB in both tests.
Mild EIB is common in Finnish elite runners and is strongly associated with atopy. Seasonal variability affects the occurrence of EIB, and thus exercise testing should be performed in both cold winter air and the pollen season to detect EIB in elite runners.
研究影响精英跑步运动员运动诱发支气管痉挛(EIB)发生的因素。
58名精英跑步运动员自愿参与,其中79%属于芬兰国家队。运动员回答了关于呼吸道症状的问卷。采用皮肤点刺试验调查特应性,用肺功能仪检测冬季零下温度下运动激发试验(ECT)后及夏季桦树花粉季节末类似ECT后静息时的肺功能。
58名跑步运动员中有5名(9%)出现明确的EIB(一秒用力呼气量(FEV1)运动后下降10%或更多)。选取19名无特应性、无症状且无哮喘家族史的跑步运动员组成亚组,以确定FEV1运动后下降的正常范围。当将该组FEV1运动诱发变化的平均值减去2个标准差(FEV1下降6.5%或更多)作为参考范围的下限,15名(26%)跑步运动员在冬季或花粉季节可能患有EIB。可能的EIB的发生取决于特应性(优势比随皮肤点刺试验阳性反应数量增加,p<0.05)。在冬季和花粉季节均接受挑战的41名跑步运动员中,9名(22%)仅在冬季可能患有EIB,3名(7%)仅在花粉季节患有EIB。只有1名跑步运动员(2%)在两次测试中均出现EIB。
轻度EIB在芬兰精英跑步运动员中很常见,且与特应性密切相关。季节变异性影响EIB的发生,因此应在寒冷的冬季空气和花粉季节进行运动测试,以检测精英跑步运动员中的EIB。